Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Sosei Group Corporation

www.sosei.com

Kojimachi Tsuruya Hachiman Bldg. 5F
2-4 Kojimachi, Chiyodaku-ku
Tokyo
102-0083
Japan

T+81-(0)3-5210-3399

Activities

Ingredients | Research & Development | Pharmaceutical

Related Companies

  • Lonza
  • Icrom SRL
  • Nanoform
  • Merck Life Science KGaA
  • Starlab
  • Edwards Vacuum
  • PCI Pharma Services
  • Curia
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • JRS Pharma
  • Hermes Pharma GmbH
  • Rousselot
  • Ecolab Life Sciences
  • Marchesini Group
  • Vectorbuilder Inc
  • Rentschler Biopharma SE
  • Indena
  • Quotient Sciences

Related Content

Metrion and Sosei Heptares to explore structure-based drug design
Metrion and Sosei Heptares to explore structure-based drug design
Sosei Heptares and PharmEnable enter drug discovery collaboration
Sosei Heptares and PharmEnable enter drug discovery collaboration
Sosei Heptares announces €40 million Medicxi investment
Sosei Heptares announces €40 million Medicxi investment
Sosei appoints Interim CFO
Sosei appoints Interim CFO
Changes in executive management at Sosei
Changes in executive management at Sosei
Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017
Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017
Heptares Therapeutics enters agreement with Daichi Sankyo
Heptares Therapeutics enters agreement with Daichi Sankyo
Sosei appoints Andrew Oakley as CFO
Sosei appoints Andrew Oakley as CFO
Heptares and Jitsubo to develop novel GPCR-targeting peptide candidates for severe gastrointestinal disorders
Heptares and Jitsubo to develop novel GPCR-targeting peptide candidates for severe gastrointestinal disorders
Heptares and Kymab enter into novel antibody therapeutics collaboration
Heptares and Kymab enter into novel antibody therapeutics collaboration
Sosei appoints Peter Bains as COO and President elect
Sosei appoints Peter Bains as COO and President elect
Pfizer agrees drug discovery collaboration with Heptares focused on GPCR targets
Pfizer agrees drug discovery collaboration with Heptares focused on GPCR targets
Teva buys rights to develop small-molecule CGRP antagonists
Teva buys rights to develop small-molecule CGRP antagonists
AstraZeneca signs a deal with Heptares that could be worth up to US$500m
AstraZeneca signs a deal with Heptares that could be worth up to US$500m
Sosei acquires Heptares Therapeutics for up to US$400m
Sosei acquires Heptares Therapeutics for up to US$400m
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company